{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T06:47:23Z","timestamp":1784011643301,"version":"3.55.0"},"reference-count":29,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.0313","type":"journal-article","created":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T16:17:11Z","timestamp":1614615431000},"page":"e210313","source":"Crossref","is-referenced-by-count":10,"title":["Association of Anti\u2013Tumor Necrosis Factor Therapy With Mortality Among Veterans With Inflammatory Bowel Disease"],"prefix":"10.1001","volume":"4","author":[{"given":"Shirley","family":"Cohen-Mekelburg","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor"},{"name":"Veterans Affairs Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan"},{"name":"Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth I.","family":"Wallace","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor"},{"name":"Veterans Affairs Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan"},{"name":"Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Van","sequence":"additional","affiliation":[{"name":"Veterans Affairs Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wyndy L.","family":"Wiitala","sequence":"additional","affiliation":[{"name":"Veterans Affairs Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shail M.","family":"Govani","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology, South Texas Veterans Healthcare System, San Antonio"},{"name":"Department of Medicine, Division of Gastroenterology, UT Health San Antonio, San Antonio, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Burns","sequence":"additional","affiliation":[{"name":"Veterans Affairs Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Lipson","sequence":"additional","affiliation":[{"name":"Veterans Affairs Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifeng","family":"Yun","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, School of Public Health, University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Hou","sequence":"additional","affiliation":[{"name":"Center for Innovations in Quality, Effectiveness, and Safety, Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas"},{"name":"Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Lewis","sequence":"additional","affiliation":[{"name":"Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia"},{"name":"Division of Gastroenterology, University of Pennsylvania, Philadelphia"},{"name":"Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Dominitz","sequence":"additional","affiliation":[{"name":"Center for Innovations in Quality, Effectiveness, and Safety, Veterans Affairs Puget Sound Health Care System, Seattle, Washington"},{"name":"Department of Internal Medicine, Division of Gastroenterology, University of Washington School of Medicine, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akbar K.","family":"Waljee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor"},{"name":"Veterans Affairs Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan"},{"name":"Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor"},{"name":"Michigan Integrated Center for Health Analytics and Medical Prediction, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,3,1]]},"reference":[{"issue":"2","key":"zoi210021r1","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/MIB.0000000000000272","article-title":"Health-related quality of life in inflammatory bowel disease in a European-wide population-based cohort 10 years after diagnosis.","volume":"21","author":"Huppertz-Hauss","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"zoi210021r2","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1053\/j.gastro.2013.10.047","article-title":"American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-a biologic drugs for the induction and maintenance of remission in inflammatory Crohn\u2019s disease.","volume":"145","author":"Terdiman","year":"2013","journal-title":"Gastroenterology"},{"issue":"1","key":"zoi210021r3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cgh.2019.02.044","article-title":"Comparative risk of serious infections with biologic and\/or immunosuppressive therapy in patients with inflammatory bowel diseases: a systematic review and meta-analysis.","volume":"18","author":"Singh","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9317","key":"zoi210021r4","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","article-title":"Maintenance infliximab for Crohn\u2019s disease: the ACCENT I randomised trial.","volume":"359","author":"Hanauer","year":"2002","journal-title":"Lancet"},{"issue":"15","key":"zoi210021r5","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1056\/NEJMoa0904492","article-title":"Infliximab, azathioprine, or combination therapy for Crohn\u2019s disease.","volume":"362","author":"Colombel","year":"2010","journal-title":"N Engl J Med"},{"key":"zoi210021r6","doi-asserted-by":"publisher","first-page":"j1415","DOI":"10.1136\/bmj.j1415","article-title":"Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study.","volume":"357","author":"Waljee","year":"2017","journal-title":"BMJ"},{"issue":"6","key":"zoi210021r7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158017","article-title":"Corticosteroid use and complications in a US inflammatory bowel disease cohort.","volume":"11","author":"Waljee","year":"2016","journal-title":"PLoS One"},{"issue":"12","key":"zoi210021r8","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1080\/17474124.2018.1545574","article-title":"Adverse events in IBD therapy: the 2018 update.","volume":"12","author":"Quezada","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"3","key":"zoi210021r9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/ajg.2017.479","article-title":"Increased mortality rates with prolonged corticosteroid therapy when compared with antitumor necrosis factor-a\u2013directed therapy for inflammatory bowel disease.","volume":"113","author":"Lewis","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"zoi210021r10","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/ajg.2012.218","article-title":"Serious infection and mortality in patients with Crohn\u2019s disease: more than 5 years of follow-up in the TREAT registry.","volume":"107","author":"Lichtenstein","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"zoi210021r11","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1053\/j.gastro.2007.09.022","article-title":"Mortality by medication use among patients with inflammatory bowel disease, 1996-2003.","volume":"133","author":"Hutfless","year":"2007","journal-title":"Gastroenterology"},{"issue":"2","key":"zoi210021r12","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1053\/j.gastro.2020.05.032","article-title":"Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry.","volume":"159","author":"Brenner","year":"2020","journal-title":"Gastroenterology"},{"key":"zoi210021r13","author":"Barnes","year":"2020","journal-title":"J Crohns Colitis"},{"issue":"3","key":"zoi210021r14","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/j.gastro.2017.10.034","article-title":"Incidence and treatment of patients diagnosed with inflammatory bowel diseases at 60 years or older in Sweden.","volume":"154","author":"Everhov","year":"2018","journal-title":"Gastroenterology"},{"issue":"11","key":"zoi210021r16","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1038\/ajg.2014.313","article-title":"Oral corticosteroids and the risk of serious infections in patients with elderly-onset inflammatory bowel diseases.","volume":"109","author":"Brassard","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"zoi210021r17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-007771","article-title":"Multimorbidity and healthcare utilisation among high-cost patients in the US Veterans Affairs Health Care System.","volume":"5","author":"Zulman","year":"2015","journal-title":"BMJ Open"},{"issue":"7","key":"zoi210021r18","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1136\/annrheumdis-2013-203243","article-title":"A two-step treatment strategy trial in patients with early arthritis aimed at achieving remission: the IMPROVED Study.","volume":"73","author":"Heimans","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"zoi210021r19","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/S1047-2797(01)00211-3","article-title":"Assessment of vital status in Department of Veterans Affairs national databases: comparison with state death certificates.","volume":"11","author":"Dominitz","year":"2001","journal-title":"Ann Epidemiol"},{"issue":"5","key":"zoi210021r20","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal structural models and causal inference in epidemiology.","volume":"11","author":"Robins","year":"2000","journal-title":"Epidemiology"},{"issue":"25","key":"zoi210021r21","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples.","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"issue":"1","key":"zoi210021r22","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12874-017-0338-0","article-title":"Double-adjustment in propensity score matching analysis: choosing a threshold for considering residual imbalance.","volume":"17","author":"Nguyen","year":"2017","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"zoi210021r23","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/MCG.0000000000000779","article-title":"There is significant practice pattern variability in the management of the hospitalized ulcerative colitis patient at a tertiary care and IBD referral center.","volume":"52","author":"Shah","year":"2018","journal-title":"J Clin Gastroenterol"},{"issue":"10","key":"zoi210021r24","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.mayocp.2018.03.004","article-title":"Overall and cause-specific mortality of inflammatory bowel disease in Olmsted County, Minnesota, from 1970 through 2016.","volume":"93","author":"Aniwan","year":"2018","journal-title":"Mayo Clin Proc"},{"issue":"10","key":"zoi210021r25","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1097\/MIB.0000000000000880","article-title":"Top-down versus step-up prescribing strategies for tumor necrosis factor alpha inhibitors in children and young adults with inflammatory bowel disease.","volume":"22","author":"Lee","year":"2016","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"zoi210021r26","doi-asserted-by":"publisher","first-page":"475","DOI":"10.5217\/ir.2017.15.4.475","article-title":"Efficacy and safety of ustekinumab in Japanese patients with moderately to severely active Crohn\u2019s disease: a subpopulation analysis of phase 3 induction and maintenance studies.","volume":"15","author":"Hibi","year":"2017","journal-title":"Intest Res"},{"issue":"12","key":"zoi210021r27","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8122140","article-title":"Short and long-term effectiveness of ustekinumab in patients with Crohn\u2019s disease: real-world data from a German IBD cohort.","volume":"8","author":"Kubesch","year":"2019","journal-title":"J Clin Med"},{"issue":"8","key":"zoi210021r28","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1097\/MIB.0000000000000817","article-title":"Age disparities in the use of steroid-sparing therapy for inflammatory bowel disease.","volume":"22","author":"Govani","year":"2016","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"zoi210021r29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/ibd\/izx007","article-title":"Predicting hospitalization and outpatient corticosteroid use in inflammatory bowel disease patients using machine learning.","volume":"24","author":"Waljee","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"zoi210021r15","author":"National Academies of Sciences, Engineering, and Medicine; Division of Behavioral and Social Sciences and Education; Board on Human-Systems Integration; Division on Engineering and Physical Sciences; Board on Infrastructure and the Constructed Environment; Committee on Facilities Staffing Requirements for Veterans Health Administration"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2776806\/cohenmekelburg_2021_oi_210021_1613597845.10055.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T16:17:16Z","timestamp":1614615436000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2776806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,1]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.0313","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,1]]}}}